Collaborative Success Stories: Small Talk, Big Walk
A company based on technology developed at the University of Missouri uses tiny nanoparticles for big impact.
Nanoparticle BioChem, Inc. (NBI) investigates and produces nanoparticle-based products for biomedical applications. It was founded by an interdisciplinary team of University of Missouri chemists, physicists and radiologists Dr. Kattesh Katti, Dr. Raghuraman Kannan, Dr. Anandhi Upendran, Kativa Katti, and Dr. Henry White.
One of NBI’s success stories is the development of therapeutic agents for treating prostate cancer. In 2010, researchers announced a partnership with Indian pharmaceutical company Shasun to commercialize a cancer treatment using gold nanoparticles. The company has since focused on consumer and safety products that hit close to home and have the potential for mass production, using silver-based nanoparticles to produce antimicrobial agents with important applications for production of antimicrobial textiles for the defense, health, hospitality and hygiene industries.
In 2012, NBI was selected by the Small Business Administration to receive the prestigious Tibetts Award in White house. The award is given to companies that serve as a model of excellence in small business innovation research programs.
Dr. Kattesh Katti is Curators’ Professor of Physics and Radiology; Dr. Raghuraman Kannan is Michael J. and Sharon R. Bukstein Chair in Cancer Research, Dr. Anandhi Upendran is director of biomedical innovations; and Kativa Katti is a lead scientist in radiology. All have appointments in the School of Medicine, and Kannan has a joint appointment in the College of Engineering. Dr. Henry White is Emeritus Professor of Physics.
Click here to download a PDF of this story.
One Health/One Medicine